Castleark Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $9.46M | Sell |
|
|||||
|
2021
Q2 | $9M | Buy |
|
|||||
|
2021
Q1 | $8.5M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $3K | Hold |
|
|||||
|
2020
Q2 | $3K | Hold |
|
|||||
|
2020
Q1 | $3K | Hold |
|
|||||
|
2019
Q4 | $7K | Hold |
|
|||||
|
2019
Q3 | $7K | Sell |
|
|||||
|
2019
Q2 | $590K | Sell |
|
|||||
|
2019
Q1 | $756K | Hold |
|
|||||
|
2018
Q4 | $662K | Hold |
|
|||||
|
2018
Q3 | $1.05M | Hold |
|
|||||
|
2018
Q2 | $851K | Hold |
|
|||||
|
2018
Q1 | $673K | Hold |
|
|||||
|
2017
Q4 | $782K | Sell |
|
|||||
|
2017
Q3 | $16.1M | Buy |
|
|||||
|
2017
Q2 | $588K | Hold |
|
|||||
|
2017
Q1 | $437K | Hold |
|
|||||
|
2016
Q4 | $379K | Hold |
|
|||||
|
2016
Q3 | $468K | Hold |
|
|||||
|
2016
Q2 | $696K | Sell |
|
|||||
|
2016
Q1 | $9.04M | Sell |
|
|||||
|
2015
Q4 | $13.3M | Sell |
|
|||||
|
2015
Q3 | $11.8M | Buy |
|
|||||
|
2015
Q2 | $892K | Hold |
|
|||||
|
2015
Q1 | $929K | Hold |
|
|||||
|
2014
Q4 | $894K | Sell |
|
|||||
|
2014
Q3 | $906K | Hold |
|
|||||
|
2014
Q2 | $1.03M | Hold |
|
|||||
|
2014
Q1 | $906K | Hold |
|
|||||
|
2013
Q4 | $556K | Buy |
|
|||||
|
2013
Q3 | $1.01M | Sell |
|
|||||
|
2013
Q2 | $841K | Buy |
|